Form 4: Novanta Director Sells All Common Stock Holdings
Insider Transaction Report
Novanta Inc. Director Thomas N. Secor reported the sale of 747 shares of common stock at $120.16 per share, reducing his direct beneficial ownership to zero.
Summary
- Director Thomas N. Secor of Novanta Inc. (NOVT) reported a transaction involving the sale of common stock.
- The transaction occurred on December 22, 2025, and involved the disposition of 747 shares of Novanta Inc. Common Stock.
- Each share was sold at a price of $120.16.
- Following this transaction, Secor's direct beneficial ownership of Common Stock is 0 shares.
- The sale was executed pursuant to a pre-established Rule 10b5-1 trading plan, which was adopted on September 10, 2025.
Sentiment
Score: 4
Explanation: A director sold all directly held common stock, which can be perceived negatively by the market. However, the sale was executed under a pre-established Rule 10b5-1 trading plan, suggesting it was a planned divestment rather than a reaction to new adverse company-specific information.
Positives
- The sale was executed under a pre-established Rule 10b5-1 trading plan, indicating a planned transaction rather than an immediate reaction to new, adverse company-specific information.
Negatives
- A director, Thomas N. Secor, sold all 747 shares of his directly held common stock, reducing his beneficial ownership to zero.
- Insider selling, even if pre-planned, can sometimes be perceived negatively by the market as a signal of reduced confidence.
Risks
- Potential negative market perception due to insider selling, which could lead to downward pressure on the stock price.
- The complete divestment of directly held shares by a director might raise questions among investors regarding future company prospects, despite the existence of a 10b5-1 plan.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Shareholders: May interpret the director's sale as a lack of confidence, potentially leading to negative sentiment or downward pressure on the stock price, despite the pre-planned nature of the transaction.
Key Dates
| Date | Description |
|---|---|
| 09/10/2025 | Date the Rule 10b5-1 trading plan was adopted by the reporting person. |
| 12/22/2025 | Date of the reported transaction (sale of common stock). |
| 12/23/2025 | Date the Form 4 was signed by the attorney-in-fact. |
Recommendation
holdWhile a director's full divestment of directly held common stock can be a bearish signal, the transaction was executed under a pre-established Rule 10b5-1 trading plan. This suggests a planned personal financial move rather than a reaction to new, adverse company information. Investors should monitor future insider activity and broader company fundamentals, but this single event, while notable, does not immediately warrant a 'sell' recommendation without further context. A 'hold' stance is appropriate to assess the broader implications.
Keywords
Novanta Inc., NOVT, Form 4, Insider Trading, Stock Sale, Director, Thomas N. Secor, Rule 10b5-1
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.